默克中国换帅;和誉医药KRAS G12D抑制剂在美国获批临床

氨基观察
Dec 03

默克中国人事调整。12月2日,默克中国宣布,现任默克全球心血管代谢与内分泌业务高级副总裁Andre Musto(穆安德)将出任默克中国医药健康业务新任董事总经理,任命将于2026年2月1日正式生效。Andre Musto先生2014年7月加入默克,出任澳大利亚与新西兰总经理和董事总经理,2016年4月出任亚太发达市场区域副总裁,2018年1月出任亚太地区副总裁,2020年5月出任全球心血管代谢与...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10